EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic effects of halothane and quinidine on canine Purkinje fibers: evidence for a synergistic interaction


Anesthesiology 65(3): 278-285
Electrophysiologic effects of halothane and quinidine on canine Purkinje fibers: evidence for a synergistic interaction
The authors studied possible interactions between halothane and quinidine on the action potentials of canine Purkinje fibers superfused with Tyrode's solution. Using standard microelectrode techniques and a physiologic pacing rate (2 Hz), halothane in concentrations from 0.5% to 2% decreased the action potential duration to 50% repolarization (ADP50). Total APD (APD100), in contrast, increased after 1% and 2% halothane. Resting membrane potential (RMP) and action potential amplitude (APamp) increased after 0.5% halothane, but returned to control with higher halothane levels. Conduction time (CT) increased at each halothane level. Pacing at faster (3 Hz) or slower (1 Hz) rates did not markedly alter the effects of halothane. Quinidine 1 .times. 10-5 M depressed the phase O upstroke (Vmax) and prolonged APD100 and CT. When halothane was added, RMP and APamp decreased, Vmax decreased further, and APD100 and CT were markedly prolonged. This resulted in conduction block or inexcitability, especially at faster pacing rates (3 Hz). Synergistic interactions between halothane and quinidine were found on RMP, APamp, APD100, and CT. Effects on Vmax, APD50, and action potential duration to 90% repolarization (APD90) were additive. It is concluded that quinidine and halothane act synergistically to decrease action potential amplitude, lower RMP, and prolong conduction. Severe depression of conduction often progressed to conduction block or inexcitability when halothane, 2% was administered during superfusion with therapeutic concentrations of quinidine.


Accession: 005349300

PMID: 3752573



Related references

The electrophysiologic effects of amiodarone and halothane on canine Purkinje fibers. Anesthesiology 75(1): 106-112, 1991

Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers. Journal of Cardiovascular Pharmacology 8(6): 1138-1143, 1986

Electrophysiologic effects of quinidine in canine purkinje fibers do not reach a steady state for several hours. FASEB Journal 2(5): ABSTRACT 5703, 1988

Electrophysiologic and inotropic effects of lnc 834 a novel quinidine analog and quinidine in calf purkinje fibers and ventricular muscle. FASEB Journal 3(4): A1204, 1989

Electrophysiologic effects of amiloride in canine Purkinje fibers: evidence for a delayed effect on repolarization. Journal of Pharmacology and Experimental Therapeutics 232(2): 485-491, 1985

Electrophysiologic effects of propafenone and metabolites on canine purkinje fibers. Federation Proceedings 46(3): 871, 1987

The effects of lidocaine on the canine ECG and electrophysiologic properties of Purkinje fibers. American Heart Journal 91(2): 191-202, 1976

Electro physiologic effects of quinidine and extracellular ph on canine purkinje fibers. Clinical Research 27(4): 618A, 1979

pH-dependent electrophysiological effects of quinidine and lidocaine on canine cardiac purkinje fibers. Circulation Research 48(1): 55-61, 1981

Electrophysiologic effects of RS-2135, a new antiarrhythmic compound, on canine Purkinje fibers. Journal of Cardiovascular Pharmacology 20(6): 955-960, 1992